Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a group of four distinct signaling proteins that are central to cellular responses to growth factors and inflammatory cytokines: RELA (p65), JUN (c-Jun), FOS (c-Fos), and MAPK1 (ERK2). RELA is a primary subunit of the NF-kappaB transcription factor complex, which plays a pivotal role in the inflammatory response and cell survival pathways (UniProt Q04206). JUN and FOS are components of the Activator Protein-1 (AP-1) transcription factor complex, which converts extracellular signals into changes in gene expression related to proliferation and apoptosis (UniProt P05412, P01100). MAPK1, also known as ERK2, is a serine/threonine kinase that serves as a critical node in the MAPK/ERK pathway, phosphorylating numerous targets including JUN and FOS to promote cell cycle progression (UniProt P28482). Together, these molecules form a highly interconnected signaling network frequently dysregulated in human cancers and chronic inflammatory diseases. Because this target string represents multiple distinct proteins rather than a single therapeutic target or a single stable biochemical complex, it is categorized as a multi-target signaling set.
Inhibition of mitogen-activated protein kinase activity (MAPK1), inhibition of proteasomal degradation of IkappaB to prevent RELA nuclear translocation, and disruption of AP-1 (JUN/FOS) transcriptional activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor and kinase signaling network (RELA, JUN, FOS, MAPK1) (RELA/JUN/FOS/MAPK1).